Quest in broad deal with CDC for hepatitis analysis

January 27, 2015 8:00 PM

14 0

(Reuters) - Laboratory testing company Quest Diagnostics Inc said on Tuesday it had signed a $520,000 agreement with the Centers for Disease Control and Prevention to identify trends in screening, diagnosis and treatment of four strains of viral hepatitis.

Quest will provide the U.S. public health agency with analytics and access to Quest's national database of clinical testing hepatitis data, which includes information from more than 20 billion test results.

Also read: Experimental Ebola Treatment May Be Deployed to Congo

Read more

To category page